Treatment of helicobacter with isothiocyanates
DCFirst Claim
Patent Images
1. A method of treating a subject having a Helicobacter infection comprising administering an antibacterially effective amount of a composition to said subject, said composition consisting essentially of one or more of a glucosinolate, an isothiocyanate, a derivative of a glucosinolate, or a derivative of an isothiocyanate.
2 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to methods of preventing or inhibiting the growth of Helicobacter through the use of a composition that comprises a glucosinolate, an isothiocyanate or a derivative or metabolite thereof. The present invention also relates to methods of preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer in subjects at risk for, or in need of treatment thereof.
76 Citations
51 Claims
- 1. A method of treating a subject having a Helicobacter infection comprising administering an antibacterially effective amount of a composition to said subject, said composition consisting essentially of one or more of a glucosinolate, an isothiocyanate, a derivative of a glucosinolate, or a derivative of an isothiocyanate.
- 13. A method for inhibiting the growth of Helicobacter, comprising administering to said Helicobacter an antibacterially effective amount of an agent, said agent consisting essentially of one or more of a glucosinolate, an isothiocyanate, a derivative of a glucosinolate, or a derivative of an isothiocyanate.
-
29. A method of treating a subject having a Helicobacter infection, comprising administering an antibacterially effective amount of a pharmaceutical composition to said subject, said pharmaceutical composition comprising one or more isothiocyanates selected from the group consisting of sulforaphane, sulforaphene, erysolin, erucin, iberin, alyssin, berteroin, iberverin, cheirolin, 5-methylsulfinylpentyl isothiocyanate, 6-methylsulfinylhexyl isothiocyanate, 7-methylsulfinylheptyl isothiocyanate, 8-methylsulfinyloctyl isothiocyanate, 9-methylsulfinylnonyl isothiocyanate, 10-methylsulfinyldecyl isothiocyanate, phenylethyl isothiocyanate, 4-(α
- -L-rhamnopyranosyloxy)benzyl isothiocyanate, 3-(α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, 2-(α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, 4-(4′
-O-acetyl-α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, or a derivative thereof. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36, 37, 38, 39)
- -L-rhamnopyranosyloxy)benzyl isothiocyanate, 3-(α
-
40. A method of inhibiting the growth of Helicobacter comprising administering to said Helicobacter an antibacterially effective amount of a pharmaceutical composition, said pharmaceutical composition comprising one or more isothiocyanates selected from the group consisting of sulforaphane, sulforaphene, erysolin, erucin, iberin, alyssin, berteroin, iberverin, cheirolin, 5-methylsulfinylpentyl isothiocyanate, 6-methylsulfinylhexyl isothiocyanate, 7-methylsulfinylheptyl isothiocyanate, 8-methylsulfinyloctyl isothiocyanate, 9-methylsulfinylnonyl isothiocyanate, 10-methylsulfinyldecyl isothiocyanate, phenylethyl isothiocyanate, 4-(α
- -L-rhamnopyranosyloxy)benzyl isothiocyanate, 3-(α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, 2-(α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, 4-(4′
-O-acetyl-α
-L-rhamnopyranosyloxy)benzyl isothiocyanate, or a derivative thereof. - View Dependent Claims (41, 42, 43, 44, 45, 46, 47)
- -L-rhamnopyranosyloxy)benzyl isothiocyanate, 3-(α
Specification